Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “C. Diff. Infections”

280 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 280 results

Not applicableStudy completedNCT02747017
What this trial is testing

Observational Study of C. Diff in Post-Transplant Patients

Who this might be right for
Clostridium Difficile
University of Minnesota 132
Large-scale testing (Phase 3)Study completedNCT05831189
What this trial is testing

A Multi-center, Single-arm Trial Exploring the Safety and Clinical Effectiveness of RBX2660 Administered by Colonoscopy to Adults With Recurrent Clostridioides Difficile Infection

Who this might be right for
Clostridium Difficile Infection Recurrence
Ferring Pharmaceuticals 41
Testing effectiveness (Phase 2)WithdrawnNCT03643887
What this trial is testing

Phase II Trial of Fecal Microbiota Transplant (FMT) for VRE and CRE Patients

Who this might be right for
Clostridium Difficile Infection
University of Wisconsin, Madison
Not applicableStudy completedNCT02461901
What this trial is testing

Does Fidaxomicin Therapy Reduce Spread of Clostridium Difficile?

Who this might be right for
Clostridium Difficile Infection
Professor Mark Wilcox 203
Testing effectiveness (Phase 2)WithdrawnNCT01077245
What this trial is testing

Safety and Clinical Effectiveness of Oral Probiotic MIYA-BM to Prevent Recurrent Clostridium Difficile Infections

Who this might be right for
Clostridium Difficile Infection
Osel, Inc.
Large-scale testing (Phase 3)Study completedNCT05320068
What this trial is testing

Oral Vancomycin Vs Placebo in the Prevention of Recurrence of Clostridioides Difficile's Infection

Who this might be right for
Clostridioides Difficile Infection
Julia Orígüen 24
Not applicableStudy completedNCT00446355
What this trial is testing

Clinical Outcomes of Patients With Clostridium Difficile Associated Disease Attributable to Diverse tcdC Genotypes

Who this might be right for
Clostridium Infections
University of Pittsburgh 1,000
Post-approval studies (Phase 4)Study completedNCT02254967
What this trial is testing

A Phase IIIB/IV Study to Compare the Efficacy of Vancomycin Therapy to Extended Duration of Fidaxomicin Therapy in the Clinical Cure of Clostridium Difficile Infection (CDI) in an Older Population

Who this might be right for
Clostridium Difficile
Astellas Pharma Europe Ltd. 364
Large-scale testing (Phase 3)WithdrawnNCT07221708
What this trial is testing

Primary Prophylaxis of Clostridioides Difficile Infection With Oral Vancomycin

Who this might be right for
Clostridioides DifficileVancomycin Resistance Enterococcus Faecium
University of Maryland, Baltimore
Large-scale testing (Phase 3)Ended earlyNCT01226992
What this trial is testing

Oral Vancomycin Followed by Fecal Transplant Versus Tapering Oral Vancomycin

Who this might be right for
Recurrent Clostridium Difficile InfectionLaboratory Confirmed Clostridium Difficile Infection
University Health Network, Toronto 81
Early research (Phase 1)Study completedNCT01551004
What this trial is testing

Phase I Trial of a Single Dose of CRS3123

Who this might be right for
Clostridium Difficile Colitis
National Institute of Allergy and Infectious Diseases (NIAID) 40
Testing effectiveness (Phase 2)UnknownNCT03988855
What this trial is testing

An Exploratory, Open-Label, Oligo-Center Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Intravenous DNV3837 in Subjects With Clostridium Difficile Infection

Who this might be right for
Clostridium Difficile (C. Difficile)
Deinove 40
Early research (Phase 1)Study completedNCT03827447
What this trial is testing

Vancomycin for the Treatment of NAAT(+)/Toxin(-) C. Difficile

Who this might be right for
Clostridium Difficile Infection
Medical College of Wisconsin 7
Early research (Phase 1)Study completedNCT02981316
What this trial is testing

Treatment of Recurrent Clostridium Difficile Infection With RBX7455

Who this might be right for
Clostridium Difficile Infection
Mayo Clinic 30
Early research (Phase 1)Looking for participantsNCT07401680
What this trial is testing

Fecal Microbiota Transplantation in an Expanded Ulcerative Colitis Population

Who this might be right for
Ulcerative ColitisInflammatory Bowel DiseasesClostridioides Difficile Infection
University of Alberta 85
Not applicableEnded earlyNCT02730325
What this trial is testing

To Evaluate the Impact of SBI on C. Difficile in Hospitalized UC Patients

Who this might be right for
Clostridium Difficile
Northwestern University 10
Not applicableStudy completedNCT01560832
What this trial is testing

Descriptive Epidemiology of Clostridium Difficile Infection in Hospitalized Adult Patients in the Asia Pacific Region

Who this might be right for
Clostridium Difficile Infection
Yonsei University 188
Testing effectiveness (Phase 2)Study completedNCT01085591
What this trial is testing

Study of CB-183,315 in Participants With Clostridium Difficile Infection

Who this might be right for
Clostridium Difficile InfectionDiarrhea
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 210
Early research (Phase 1)Study completedNCT06639997
What this trial is testing

Safety and Tolerability of AZD5148 in Japanese Participants

Who this might be right for
Clostridioides Difficile Infection
AstraZeneca 16
Not applicableStudy completedNCT03349268
What this trial is testing

Pulsed UV Xenon Disinfection to Prevent Resistant Healthcare Associated Infection

Who this might be right for
Healthcare Associated InfectionClostridium Difficile InfectionInfection Due to Multidrug Resistant Bacteria
University of Michigan 25,732
Next Page